209 related articles for article (PubMed ID: 22970170)
1. A novel in vivo siRNA delivery system specifically targeting liver cells for protection of ConA-induced fulminant hepatitis.
Jiang N; Zhang X; Zheng X; Chen D; Siu K; Wang H; Ichim TE; Quan D; McAlister V; Chen G; Min WP
PLoS One; 2012; 7(9):e44138. PubMed ID: 22970170
[TBL] [Abstract][Full Text] [Related]
2. Targeted gene silencing of TLR4 using liposomal nanoparticles for preventing liver ischemia reperfusion injury.
Jiang N; Zhang X; Zheng X; Chen D; Zhang Y; Siu LK; Xin HB; Li R; Zhao H; Riordan N; Ichim TE; Quan D; Jevnikar AM; Chen G; Min W
Am J Transplant; 2011 Sep; 11(9):1835-44. PubMed ID: 21794086
[TBL] [Abstract][Full Text] [Related]
3. RNA interference targeting Fas protects mice from fulminant hepatitis.
Song E; Lee SK; Wang J; Ince N; Ouyang N; Min J; Chen J; Shankar P; Lieberman J
Nat Med; 2003 Mar; 9(3):347-51. PubMed ID: 12579197
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin small interfering RNA protects mice from fulminant hepatitis.
Saito Y; Kon S; Fujiwara Y; Nakayama Y; Kurotaki D; Fukuda N; Kimura C; Kanayama M; Ito K; Diao H; Matsui Y; Komatsu Y; Ohtsuka E; Uede T
Hum Gene Ther; 2007 Dec; 18(12):1205-14. PubMed ID: 17988193
[TBL] [Abstract][Full Text] [Related]
5. Superparamagnetic iron oxide nanoparticles modified with polyethylenimine and galactose for siRNA targeted delivery in hepatocellular carcinoma therapy.
Yang Z; Duan J; Wang J; Liu Q; Shang R; Yang X; Lu P; Xia C; Wang L; Dou K
Int J Nanomedicine; 2018; 13():1851-1865. PubMed ID: 29618926
[TBL] [Abstract][Full Text] [Related]
6. The protective effect of the natural compound hesperetin against fulminant hepatitis in vivo and in vitro.
Bai X; Yang P; Zhou Q; Cai B; Buist-Homan M; Cheng H; Jiang J; Shen D; Li L; Luo X; Faber KN; Moshage H; Shi G
Br J Pharmacol; 2017 Jan; 174(1):41-56. PubMed ID: 27714757
[TBL] [Abstract][Full Text] [Related]
7. Alleviation of ischemia-reperfusion injury in rat liver transplantation by induction of small interference RNA targeting Fas.
Li X; Zhang JF; Lu MQ; Yang Y; Xu C; Li H; Wang GS; Cai CJ; Chen GH
Langenbecks Arch Surg; 2007 May; 392(3):345-51. PubMed ID: 17235585
[TBL] [Abstract][Full Text] [Related]
8. N-acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liver.
Wang HX; Xiong MH; Wang YC; Zhu J; Wang J
J Control Release; 2013 Mar; 166(2):106-14. PubMed ID: 23266452
[TBL] [Abstract][Full Text] [Related]
9. Small interfering RNA delivery to the liver by intravenous administration of galactosylated cationic liposomes in mice.
Sato A; Takagi M; Shimamoto A; Kawakami S; Hashida M
Biomaterials; 2007 Mar; 28(7):1434-42. PubMed ID: 17141864
[TBL] [Abstract][Full Text] [Related]
10. In vivo siRNA delivery of Keap1 modulates death and survival signaling pathways and attenuates concanavalin-A-induced acute liver injury in mice.
González-Rodríguez Á; Reibert B; Amann T; Constien R; Rondinone CM; Valverde ÁM
Dis Model Mech; 2014 Sep; 7(9):1093-100. PubMed ID: 24997191
[TBL] [Abstract][Full Text] [Related]
11. Galactose-modified cationic liposomes as a liver-targeting delivery system for small interfering RNA.
Sonoke S; Ueda T; Fujiwara K; Kuwabara K; Yano J
Biol Pharm Bull; 2011; 34(8):1338-42. PubMed ID: 21804229
[TBL] [Abstract][Full Text] [Related]
12. Liver-specific Bid silencing inhibits APAP-induced cell death in mice.
Maxa M; Schaeper U; Dames S; Vollmar B; Kuhla A
Apoptosis; 2019 Dec; 24(11-12):934-945. PubMed ID: 31576482
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9 Technology Targeting Fas Gene Protects Mice From Concanavalin-A Induced Fulminant Hepatic Failure.
Liang WC; Liang PP; Wong CW; Ng TB; Huang JJ; Zhang JF; Waye MM; Fu WM
J Cell Biochem; 2017 Mar; 118(3):530-536. PubMed ID: 27585307
[TBL] [Abstract][Full Text] [Related]
14. Fas siRNA reduces apoptotic cell death of allogeneic-transplanted hepatocytes in mouse spleen.
Wang J; Li W; Min J; Ou Q; Chen J
Transplant Proc; 2003 Jun; 35(4):1594-5. PubMed ID: 12826229
[TBL] [Abstract][Full Text] [Related]
15. Caspase-8 and caspase-3 small interfering RNA decreases ischemia/reperfusion injury to the liver in mice.
Contreras JL; Vilatoba M; Eckstein C; Bilbao G; Anthony Thompson J; Eckhoff DE
Surgery; 2004 Aug; 136(2):390-400. PubMed ID: 15300206
[TBL] [Abstract][Full Text] [Related]
16. Asialoglycoprotein receptor-targeted liposomes loaded with a norcantharimide derivative for hepatocyte-selective targeting.
Liu X; Han M; Xu J; Geng S; Zhang Y; Ye X; Gou J; Yin T; He H; Tang X
Int J Pharm; 2017 Mar; 520(1-2):98-110. PubMed ID: 28167263
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor alpha acts as a mediator of endoplasmic reticulum stress-induced hepatocyte apoptosis in acute liver failure.
Zhang L; Ren F; Zhang X; Wang X; Shi H; Zhou L; Zheng S; Chen Y; Chen D; Li L; Zhao C; Duan Z
Dis Model Mech; 2016 Jul; 9(7):799-809. PubMed ID: 27482818
[TBL] [Abstract][Full Text] [Related]
18. Galectin‑9 ameliorates fulminant liver injury.
Tadokoro T; Morishita A; Sakamoto T; Fujihara S; Fujita K; Mimura S; Oura K; Nomura T; Tani J; Yoneyama H; Iwama H; Himoto T; Niki T; Hirashima M; Masaki T
Mol Med Rep; 2017 Jul; 16(1):36-42. PubMed ID: 28534962
[TBL] [Abstract][Full Text] [Related]
19. Hepatoma-derived growth factor participates in concanavalin A-induced hepatitis.
Wang EM; Hu TH; Huang CC; Chang YC; Yang SM; Huang ST; Wu JC; Ma YL; Chan HH; Liu LF; Lu WB; Kung ML; Wen ZH; Wang JC; Ko CY; Tsai WL; Chu TH; Tai MH
FASEB J; 2020 Dec; 34(12):16163-16178. PubMed ID: 33063394
[TBL] [Abstract][Full Text] [Related]
20. PGAM5-mediated programmed necrosis of hepatocytes drives acute liver injury.
He GW; Günther C; Kremer AE; Thonn V; Amann K; Poremba C; Neurath MF; Wirtz S; Becker C
Gut; 2017 Apr; 66(4):716-723. PubMed ID: 27566130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
